世界のメチシリン耐性黄色ブドウ球菌検査市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Methicillin-Resistant Staphylococcus Aureus Testing Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A12469 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、メチシリン耐性黄色ブドウ球菌検査のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。メチシリン耐性黄色ブドウ球菌検査の種類別市場規模（血液検査、免疫診断、その他）、用途別市場規模（病院、クリニック、診断センター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・メチシリン耐性黄色ブドウ球菌検査の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Roche、BD、Bio-Rad、Biomerieux、Abbott、Danaher、Hain Lifescience、Abacus Diagnostica、Eurofins、Puritan Medical、Arlington Scientific、Luminex ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：血液検査、免疫診断、その他 ・用途別分析2016年-2026年：病院、クリニック、診断センター、その他 ・メチシリン耐性黄色ブドウ球菌検査の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・メチシリン耐性黄色ブドウ球菌検査のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・メチシリン耐性黄色ブドウ球菌検査のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・メチシリン耐性黄色ブドウ球菌検査の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・メチシリン耐性黄色ブドウ球菌検査の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Methicillin-Resistant Staphylococcus Aureus Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Methicillin-Resistant Staphylococcus Aureus Testing size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Methicillin-Resistant Staphylococcus Aureus Testing market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Methicillin-Resistant Staphylococcus Aureus Testing market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Blood Testing
Immunodiagnostics
Others

Market segment by Application, can be divided into
Hospital
Clinic
Diagnostic Center
Others

Market segment by players, this report covers
Roche
BD
Bio-Rad
Biomerieux
Abbott
Danaher
Hain Lifescience
Abacus Diagnostica
Eurofins
Puritan Medical
Arlington Scientific
Luminex

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Methicillin-Resistant Staphylococcus Aureus Testing
1.2 Classification of Methicillin-Resistant Staphylococcus Aureus Testing by Type
1.2.1 Overview: Global Methicillin-Resistant Staphylococcus Aureus Testing Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Methicillin-Resistant Staphylococcus Aureus Testing Revenue Market Share by Type in 2020
1.2.3 Blood Testing
1.2.4 Immunodiagnostics
1.2.5 Others
1.3 Global Methicillin-Resistant Staphylococcus Aureus Testing Market by Application
1.3.1 Overview: Global Methicillin-Resistant Staphylococcus Aureus Testing Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Diagnostic Center
1.3.5 Others
1.4 Global Methicillin-Resistant Staphylococcus Aureus Testing Market Size & Forecast
1.5 Global Methicillin-Resistant Staphylococcus Aureus Testing Market Size and Forecast by Region
1.5.1 Global Methicillin-Resistant Staphylococcus Aureus Testing Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Methicillin-Resistant Staphylococcus Aureus Testing Market Size by Region, (2016-2021)
1.5.3 North America Methicillin-Resistant Staphylococcus Aureus Testing Market Size and Prospect (2016-2026)
1.5.4 Europe Methicillin-Resistant Staphylococcus Aureus Testing Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Methicillin-Resistant Staphylococcus Aureus Testing Market Size and Prospect (2016-2026)
1.5.6 South America Methicillin-Resistant Staphylococcus Aureus Testing Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Methicillin-Resistant Staphylococcus Aureus Testing Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Methicillin-Resistant Staphylococcus Aureus Testing Market Drivers
1.6.2 Methicillin-Resistant Staphylococcus Aureus Testing Market Restraints
1.6.3 Methicillin-Resistant Staphylococcus Aureus Testing Trends Analysis
2 Company Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Methicillin-Resistant Staphylococcus Aureus Testing Product and Solutions
2.1.4 Roche Methicillin-Resistant Staphylococcus Aureus Testing Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Roche Recent Developments and Future Plans
2.2 BD
2.2.1 BD Details
2.2.2 BD Major Business
2.2.3 BD Methicillin-Resistant Staphylococcus Aureus Testing Product and Solutions
2.2.4 BD Methicillin-Resistant Staphylococcus Aureus Testing Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 BD Recent Developments and Future Plans
2.3 Bio-Rad
2.3.1 Bio-Rad Details
2.3.2 Bio-Rad Major Business
2.3.3 Bio-Rad Methicillin-Resistant Staphylococcus Aureus Testing Product and Solutions
2.3.4 Bio-Rad Methicillin-Resistant Staphylococcus Aureus Testing Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Bio-Rad Recent Developments and Future Plans
2.4 Biomerieux
2.4.1 Biomerieux Details
2.4.2 Biomerieux Major Business
2.4.3 Biomerieux Methicillin-Resistant Staphylococcus Aureus Testing Product and Solutions
2.4.4 Biomerieux Methicillin-Resistant Staphylococcus Aureus Testing Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Biomerieux Recent Developments and Future Plans
2.5 Abbott
2.5.1 Abbott Details
2.5.2 Abbott Major Business
2.5.3 Abbott Methicillin-Resistant Staphylococcus Aureus Testing Product and Solutions
2.5.4 Abbott Methicillin-Resistant Staphylococcus Aureus Testing Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Abbott Recent Developments and Future Plans
2.6 Danaher
2.6.1 Danaher Details
2.6.2 Danaher Major Business
2.6.3 Danaher Methicillin-Resistant Staphylococcus Aureus Testing Product and Solutions
2.6.4 Danaher Methicillin-Resistant Staphylococcus Aureus Testing Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Danaher Recent Developments and Future Plans
2.7 Hain Lifescience
2.7.1 Hain Lifescience Details
2.7.2 Hain Lifescience Major Business
2.7.3 Hain Lifescience Methicillin-Resistant Staphylococcus Aureus Testing Product and Solutions
2.7.4 Hain Lifescience Methicillin-Resistant Staphylococcus Aureus Testing Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Hain Lifescience Recent Developments and Future Plans
2.8 Abacus Diagnostica
2.8.1 Abacus Diagnostica Details
2.8.2 Abacus Diagnostica Major Business
2.8.3 Abacus Diagnostica Methicillin-Resistant Staphylococcus Aureus Testing Product and Solutions
2.8.4 Abacus Diagnostica Methicillin-Resistant Staphylococcus Aureus Testing Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Abacus Diagnostica Recent Developments and Future Plans
2.9 Eurofins
2.9.1 Eurofins Details
2.9.2 Eurofins Major Business
2.9.3 Eurofins Methicillin-Resistant Staphylococcus Aureus Testing Product and Solutions
2.9.4 Eurofins Methicillin-Resistant Staphylococcus Aureus Testing Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Eurofins Recent Developments and Future Plans
2.10 Puritan Medical
2.10.1 Puritan Medical Details
2.10.2 Puritan Medical Major Business
2.10.3 Puritan Medical Methicillin-Resistant Staphylococcus Aureus Testing Product and Solutions
2.10.4 Puritan Medical Methicillin-Resistant Staphylococcus Aureus Testing Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Puritan Medical Recent Developments and Future Plans
2.11 Arlington Scientific
2.11.1 Arlington Scientific Details
2.11.2 Arlington Scientific Major Business
2.11.3 Arlington Scientific Methicillin-Resistant Staphylococcus Aureus Testing Product and Solutions
2.11.4 Arlington Scientific Methicillin-Resistant Staphylococcus Aureus Testing Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Arlington Scientific Recent Developments and Future Plans
2.12 Luminex
2.12.1 Luminex Details
2.12.2 Luminex Major Business
2.12.3 Luminex Methicillin-Resistant Staphylococcus Aureus Testing Product and Solutions
2.12.4 Luminex Methicillin-Resistant Staphylococcus Aureus Testing Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Luminex Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Methicillin-Resistant Staphylococcus Aureus Testing Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Methicillin-Resistant Staphylococcus Aureus Testing Players Market Share
3.2.2 Top 10 Methicillin-Resistant Staphylococcus Aureus Testing Players Market Share
3.2.3 Market Competition Trend
3.3 Methicillin-Resistant Staphylococcus Aureus Testing Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Methicillin-Resistant Staphylococcus Aureus Testing Revenue and Market Share by Type (2016-2021)
4.2 Global Methicillin-Resistant Staphylococcus Aureus Testing Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Methicillin-Resistant Staphylococcus Aureus Testing Revenue Market Share by Application (2016-2021)
5.2 Methicillin-Resistant Staphylococcus Aureus Testing Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Methicillin-Resistant Staphylococcus Aureus Testing Revenue by Type (2016-2026)
6.2 North America Methicillin-Resistant Staphylococcus Aureus Testing Revenue by Application (2016-2026)
6.3 North America Methicillin-Resistant Staphylococcus Aureus Testing Market Size by Country
6.3.1 North America Methicillin-Resistant Staphylococcus Aureus Testing Revenue by Country (2016-2026)
6.3.2 United States Methicillin-Resistant Staphylococcus Aureus Testing Market Size and Forecast (2016-2026)
6.3.3 Canada Methicillin-Resistant Staphylococcus Aureus Testing Market Size and Forecast (2016-2026)
6.3.4 Mexico Methicillin-Resistant Staphylococcus Aureus Testing Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Methicillin-Resistant Staphylococcus Aureus Testing Revenue by Type (2016-2026)
7.2 Europe Methicillin-Resistant Staphylococcus Aureus Testing Revenue by Application (2016-2026)
7.3 Europe Methicillin-Resistant Staphylococcus Aureus Testing Market Size by Country
7.3.1 Europe Methicillin-Resistant Staphylococcus Aureus Testing Revenue by Country (2016-2026)
7.3.2 Germany Methicillin-Resistant Staphylococcus Aureus Testing Market Size and Forecast (2016-2026)
7.3.3 France Methicillin-Resistant Staphylococcus Aureus Testing Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Methicillin-Resistant Staphylococcus Aureus Testing Market Size and Forecast (2016-2026)
7.3.5 Russia Methicillin-Resistant Staphylococcus Aureus Testing Market Size and Forecast (2016-2026)
7.3.6 Italy Methicillin-Resistant Staphylococcus Aureus Testing Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Methicillin-Resistant Staphylococcus Aureus Testing Revenue by Type (2016-2026)
8.2 Asia-Pacific Methicillin-Resistant Staphylococcus Aureus Testing Revenue by Application (2016-2026)
8.3 Asia-Pacific Methicillin-Resistant Staphylococcus Aureus Testing Market Size by Region
8.3.1 Asia-Pacific Methicillin-Resistant Staphylococcus Aureus Testing Revenue by Region (2016-2026)
8.3.2 China Methicillin-Resistant Staphylococcus Aureus Testing Market Size and Forecast (2016-2026)
8.3.3 Japan Methicillin-Resistant Staphylococcus Aureus Testing Market Size and Forecast (2016-2026)
8.3.4 South Korea Methicillin-Resistant Staphylococcus Aureus Testing Market Size and Forecast (2016-2026)
8.3.5 India Methicillin-Resistant Staphylococcus Aureus Testing Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Methicillin-Resistant Staphylococcus Aureus Testing Market Size and Forecast (2016-2026)
8.3.7 Australia Methicillin-Resistant Staphylococcus Aureus Testing Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Methicillin-Resistant Staphylococcus Aureus Testing Revenue by Type (2016-2026)
9.2 South America Methicillin-Resistant Staphylococcus Aureus Testing Revenue by Application (2016-2026)
9.3 South America Methicillin-Resistant Staphylococcus Aureus Testing Market Size by Country
9.3.1 South America Methicillin-Resistant Staphylococcus Aureus Testing Revenue by Country (2016-2026)
9.3.2 Brazil Methicillin-Resistant Staphylococcus Aureus Testing Market Size and Forecast (2016-2026)
9.3.3 Argentina Methicillin-Resistant Staphylococcus Aureus Testing Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Methicillin-Resistant Staphylococcus Aureus Testing Revenue by Type (2016-2026)
10.2 Middle East & Africa Methicillin-Resistant Staphylococcus Aureus Testing Revenue by Application (2016-2026)
10.3 Middle East & Africa Methicillin-Resistant Staphylococcus Aureus Testing Market Size by Country
10.3.1 Middle East & Africa Methicillin-Resistant Staphylococcus Aureus Testing Revenue by Country (2016-2026)
10.3.2 Turkey Methicillin-Resistant Staphylococcus Aureus Testing Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Methicillin-Resistant Staphylococcus Aureus Testing Market Size and Forecast (2016-2026)
10.3.4 UAE Methicillin-Resistant Staphylococcus Aureus Testing Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Methicillin-Resistant Staphylococcus Aureus Testing Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Methicillin-Resistant Staphylococcus Aureus Testing Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Methicillin-Resistant Staphylococcus Aureus Testing Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Methicillin-Resistant Staphylococcus Aureus Testing Revenue (USD Million) by Region (2016-2021)
Table 5. Global Methicillin-Resistant Staphylococcus Aureus Testing Revenue Market Share by Region (2021-2026)
Table 6. Roche Corporate Information, Head Office, and Major Competitors
Table 7. Roche Major Business
Table 8. Roche Methicillin-Resistant Staphylococcus Aureus Testing Product and Solutions
Table 9. Roche Methicillin-Resistant Staphylococcus Aureus Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. BD Corporate Information, Head Office, and Major Competitors
Table 11. BD Major Business
Table 12. BD Methicillin-Resistant Staphylococcus Aureus Testing Product and Solutions
Table 13. BD Methicillin-Resistant Staphylococcus Aureus Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Bio-Rad Corporate Information, Head Office, and Major Competitors
Table 15. Bio-Rad Major Business
Table 16. Bio-Rad Methicillin-Resistant Staphylococcus Aureus Testing Product and Solutions
Table 17. Bio-Rad Methicillin-Resistant Staphylococcus Aureus Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Biomerieux Corporate Information, Head Office, and Major Competitors
Table 19. Biomerieux Major Business
Table 20. Biomerieux Methicillin-Resistant Staphylococcus Aureus Testing Product and Solutions
Table 21. Biomerieux Methicillin-Resistant Staphylococcus Aureus Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Abbott Corporate Information, Head Office, and Major Competitors
Table 23. Abbott Major Business
Table 24. Abbott Methicillin-Resistant Staphylococcus Aureus Testing Product and Solutions
Table 25. Abbott Methicillin-Resistant Staphylococcus Aureus Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Danaher Corporate Information, Head Office, and Major Competitors
Table 27. Danaher Major Business
Table 28. Danaher Methicillin-Resistant Staphylococcus Aureus Testing Product and Solutions
Table 29. Danaher Methicillin-Resistant Staphylococcus Aureus Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Hain Lifescience Corporate Information, Head Office, and Major Competitors
Table 31. Hain Lifescience Major Business
Table 32. Hain Lifescience Methicillin-Resistant Staphylococcus Aureus Testing Product and Solutions
Table 33. Hain Lifescience Methicillin-Resistant Staphylococcus Aureus Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Abacus Diagnostica Corporate Information, Head Office, and Major Competitors
Table 35. Abacus Diagnostica Major Business
Table 36. Abacus Diagnostica Methicillin-Resistant Staphylococcus Aureus Testing Product and Solutions
Table 37. Abacus Diagnostica Methicillin-Resistant Staphylococcus Aureus Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Eurofins Corporate Information, Head Office, and Major Competitors
Table 39. Eurofins Major Business
Table 40. Eurofins Methicillin-Resistant Staphylococcus Aureus Testing Product and Solutions
Table 41. Eurofins Methicillin-Resistant Staphylococcus Aureus Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Puritan Medical Corporate Information, Head Office, and Major Competitors
Table 43. Puritan Medical Major Business
Table 44. Puritan Medical Methicillin-Resistant Staphylococcus Aureus Testing Product and Solutions
Table 45. Puritan Medical Methicillin-Resistant Staphylococcus Aureus Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Arlington Scientific Corporate Information, Head Office, and Major Competitors
Table 47. Arlington Scientific Major Business
Table 48. Arlington Scientific Methicillin-Resistant Staphylococcus Aureus Testing Product and Solutions
Table 49. Arlington Scientific Methicillin-Resistant Staphylococcus Aureus Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Luminex Corporate Information, Head Office, and Major Competitors
Table 51. Luminex Major Business
Table 52. Luminex Methicillin-Resistant Staphylococcus Aureus Testing Product and Solutions
Table 53. Luminex Methicillin-Resistant Staphylococcus Aureus Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Global Methicillin-Resistant Staphylococcus Aureus Testing Revenue (USD Million) by Players (2019-2021)
Table 55. Global Methicillin-Resistant Staphylococcus Aureus Testing Revenue Share by Players (2019-2021)
Table 56. Breakdown of Methicillin-Resistant Staphylococcus Aureus Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 57. Methicillin-Resistant Staphylococcus Aureus Testing Players Head Office, Products and Services Provided
Table 58. Methicillin-Resistant Staphylococcus Aureus Testing Mergers & Acquisitions in the Past Five Years
Table 59. Methicillin-Resistant Staphylococcus Aureus Testing New Entrants and Expansion Plans
Table 60. Global Methicillin-Resistant Staphylococcus Aureus Testing Revenue (USD Million) by Type (2016-2021)
Table 61. Global Methicillin-Resistant Staphylococcus Aureus Testing Revenue Share by Type (2016-2021)
Table 62. Global Methicillin-Resistant Staphylococcus Aureus Testing Revenue Forecast by Type (2021-2026)
Table 63. Global Methicillin-Resistant Staphylococcus Aureus Testing Revenue by Application (2016-2021)
Table 64. Global Methicillin-Resistant Staphylococcus Aureus Testing Revenue Forecast by Application (2021-2026)
Table 65. North America Methicillin-Resistant Staphylococcus Aureus Testing Revenue by Type (2016-2021) & (USD Million)
Table 66. North America Methicillin-Resistant Staphylococcus Aureus Testing Revenue by Type (2021-2026) & (USD Million)
Table 67. North America Methicillin-Resistant Staphylococcus Aureus Testing Revenue by Application (2016-2021) & (USD Million)
Table 68. North America Methicillin-Resistant Staphylococcus Aureus Testing Revenue by Application (2021-2026) & (USD Million)
Table 69. North America Methicillin-Resistant Staphylococcus Aureus Testing Revenue by Country (2016-2021) & (USD Million)
Table 70. North America Methicillin-Resistant Staphylococcus Aureus Testing Revenue by Country (2021-2026) & (USD Million)
Table 71. Europe Methicillin-Resistant Staphylococcus Aureus Testing Revenue by Type (2016-2021) & (USD Million)
Table 72. Europe Methicillin-Resistant Staphylococcus Aureus Testing Revenue by Type (2021-2026) & (USD Million)
Table 73. Europe Methicillin-Resistant Staphylococcus Aureus Testing Revenue by Application (2016-2021) & (USD Million)
Table 74. Europe Methicillin-Resistant Staphylococcus Aureus Testing Revenue by Application (2021-2026) & (USD Million)
Table 75. Europe Methicillin-Resistant Staphylococcus Aureus Testing Revenue by Country (2016-2021) & (USD Million)
Table 76. Europe Methicillin-Resistant Staphylococcus Aureus Testing Revenue by Country (2021-2026) & (USD Million)
Table 77. Asia-Pacific Methicillin-Resistant Staphylococcus Aureus Testing Revenue by Type (2016-2021) & (USD Million)
Table 78. Asia-Pacific Methicillin-Resistant Staphylococcus Aureus Testing Revenue by Type (2021-2026) & (USD Million)
Table 79. Asia-Pacific Methicillin-Resistant Staphylococcus Aureus Testing Revenue by Application (2016-2021) & (USD Million)
Table 80. Asia-Pacific Methicillin-Resistant Staphylococcus Aureus Testing Revenue by Application (2021-2026) & (USD Million)
Table 81. Asia-Pacific Methicillin-Resistant Staphylococcus Aureus Testing Revenue by Region (2016-2021) & (USD Million)
Table 82. Asia-Pacific Methicillin-Resistant Staphylococcus Aureus Testing Revenue by Region (2021-2026) & (USD Million)
Table 83. South America Methicillin-Resistant Staphylococcus Aureus Testing Revenue by Type (2016-2021) & (USD Million)
Table 84. South America Methicillin-Resistant Staphylococcus Aureus Testing Revenue by Type (2021-2026) & (USD Million)
Table 85. South America Methicillin-Resistant Staphylococcus Aureus Testing Revenue by Application (2016-2021) & (USD Million)
Table 86. South America Methicillin-Resistant Staphylococcus Aureus Testing Revenue by Application (2021-2026) & (USD Million)
Table 87. South America Methicillin-Resistant Staphylococcus Aureus Testing Revenue by Country (2016-2021) & (USD Million)
Table 88. South America Methicillin-Resistant Staphylococcus Aureus Testing Revenue by Country (2021-2026) & (USD Million)
Table 89. Middle East & Africa Methicillin-Resistant Staphylococcus Aureus Testing Revenue by Type (2016-2021) & (USD Million)
Table 90. Middle East & Africa Methicillin-Resistant Staphylococcus Aureus Testing Revenue by Type (2021-2026) & (USD Million)
Table 91. Middle East & Africa Methicillin-Resistant Staphylococcus Aureus Testing Revenue by Application (2016-2021) & (USD Million)
Table 92. Middle East & Africa Methicillin-Resistant Staphylococcus Aureus Testing Revenue by Application (2021-2026) & (USD Million)
Table 93. Middle East & Africa Methicillin-Resistant Staphylococcus Aureus Testing Revenue by Country (2016-2021) & (USD Million)
Table 94. Middle East & Africa Methicillin-Resistant Staphylococcus Aureus Testing Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Methicillin-Resistant Staphylococcus Aureus Testing Picture
Figure 2. Global Methicillin-Resistant Staphylococcus Aureus Testing Revenue Market Share by Type in 2020
Figure 3. Blood Testing
Figure 4. Immunodiagnostics
Figure 5. Others
Figure 6. Methicillin-Resistant Staphylococcus Aureus Testing Revenue Market Share by Application in 2020
Figure 7. Hospital Picture
Figure 8. Clinic Picture
Figure 9. Diagnostic Center Picture
Figure 10. Others Picture
Figure 11. Global Methicillin-Resistant Staphylococcus Aureus Testing Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Methicillin-Resistant Staphylococcus Aureus Testing Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Methicillin-Resistant Staphylococcus Aureus Testing Revenue Market Share by Region (2016-2026)
Figure 14. Global Methicillin-Resistant Staphylococcus Aureus Testing Revenue Market Share by Region in 2020
Figure 15. North America Methicillin-Resistant Staphylococcus Aureus Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Methicillin-Resistant Staphylococcus Aureus Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Methicillin-Resistant Staphylococcus Aureus Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Methicillin-Resistant Staphylococcus Aureus Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Methicillin-Resistant Staphylococcus Aureus Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Methicillin-Resistant Staphylococcus Aureus Testing Market Drivers
Figure 21. Methicillin-Resistant Staphylococcus Aureus Testing Market Restraints
Figure 22. Methicillin-Resistant Staphylococcus Aureus Testing Market Trends
Figure 23. Roche Recent Developments and Future Plans
Figure 24. BD Recent Developments and Future Plans
Figure 25. Bio-Rad Recent Developments and Future Plans
Figure 26. Biomerieux Recent Developments and Future Plans
Figure 27. Abbott Recent Developments and Future Plans
Figure 28. Danaher Recent Developments and Future Plans
Figure 29. Hain Lifescience Recent Developments and Future Plans
Figure 30. Abacus Diagnostica Recent Developments and Future Plans
Figure 31. Eurofins Recent Developments and Future Plans
Figure 32. Puritan Medical Recent Developments and Future Plans
Figure 33. Arlington Scientific Recent Developments and Future Plans
Figure 34. Luminex Recent Developments and Future Plans
Figure 35. Global Methicillin-Resistant Staphylococcus Aureus Testing Revenue Share by Players in 2020
Figure 36. Methicillin-Resistant Staphylococcus Aureus Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 37. Global Top 3 Players Methicillin-Resistant Staphylococcus Aureus Testing Revenue Market Share in 2020
Figure 38. Global Top 10 Players Methicillin-Resistant Staphylococcus Aureus Testing Revenue Market Share in 2020
Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 40. Global Methicillin-Resistant Staphylococcus Aureus Testing Revenue Share by Type in 2020
Figure 41. Global Methicillin-Resistant Staphylococcus Aureus Testing Market Share Forecast by Type (2021-2026)
Figure 42. Global Methicillin-Resistant Staphylococcus Aureus Testing Revenue Share by Application in 2020
Figure 43. Global Methicillin-Resistant Staphylococcus Aureus Testing Market Share Forecast by Application (2021-2026)
Figure 44. North America Methicillin-Resistant Staphylococcus Aureus Testing Sales Market Share by Type (2016-2026)
Figure 45. North America Methicillin-Resistant Staphylococcus Aureus Testing Sales Market Share by Application (2016-2026)
Figure 46. North America Methicillin-Resistant Staphylococcus Aureus Testing Revenue Market Share by Country (2016-2026)
Figure 47. United States Methicillin-Resistant Staphylococcus Aureus Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Canada Methicillin-Resistant Staphylococcus Aureus Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Mexico Methicillin-Resistant Staphylococcus Aureus Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Europe Methicillin-Resistant Staphylococcus Aureus Testing Sales Market Share by Type (2016-2026)
Figure 51. Europe Methicillin-Resistant Staphylococcus Aureus Testing Sales Market Share by Application (2016-2026)
Figure 52. Europe Methicillin-Resistant Staphylococcus Aureus Testing Revenue Market Share by Country (2016-2026)
Figure 53. Germany Methicillin-Resistant Staphylococcus Aureus Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. France Methicillin-Resistant Staphylococcus Aureus Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. United Kingdom Methicillin-Resistant Staphylococcus Aureus Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Russia Methicillin-Resistant Staphylococcus Aureus Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Italy Methicillin-Resistant Staphylococcus Aureus Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Asia-Pacific Methicillin-Resistant Staphylococcus Aureus Testing Sales Market Share by Type (2016-2026)
Figure 59. Asia-Pacific Methicillin-Resistant Staphylococcus Aureus Testing Sales Market Share by Application (2016-2026)
Figure 60. Asia-Pacific Methicillin-Resistant Staphylococcus Aureus Testing Revenue Market Share by Region (2016-2026)
Figure 61. China Methicillin-Resistant Staphylococcus Aureus Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Japan Methicillin-Resistant Staphylococcus Aureus Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South Korea Methicillin-Resistant Staphylococcus Aureus Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. India Methicillin-Resistant Staphylococcus Aureus Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Southeast Asia Methicillin-Resistant Staphylococcus Aureus Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Australia Methicillin-Resistant Staphylococcus Aureus Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South America Methicillin-Resistant Staphylococcus Aureus Testing Sales Market Share by Type (2016-2026)
Figure 68. South America Methicillin-Resistant Staphylococcus Aureus Testing Sales Market Share by Application (2016-2026)
Figure 69. South America Methicillin-Resistant Staphylococcus Aureus Testing Revenue Market Share by Country (2016-2026)
Figure 70. Brazil Methicillin-Resistant Staphylococcus Aureus Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Argentina Methicillin-Resistant Staphylococcus Aureus Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Middle East and Africa Methicillin-Resistant Staphylococcus Aureus Testing Sales Market Share by Type (2016-2026)
Figure 73. Middle East and Africa Methicillin-Resistant Staphylococcus Aureus Testing Sales Market Share by Application (2016-2026)
Figure 74. Middle East and Africa Methicillin-Resistant Staphylococcus Aureus Testing Revenue Market Share by Country (2016-2026)
Figure 75. Turkey Methicillin-Resistant Staphylococcus Aureus Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Saudi Arabia Methicillin-Resistant Staphylococcus Aureus Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. UAE Methicillin-Resistant Staphylococcus Aureus Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Methodology
Figure 79. Research Process and Data Source

---